Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron in Overactive Bladder
NCT00662909Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Mar 2008; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00662909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00662909.